FDA Approves Fourth Product Under National Priority Voucher Program, Higher Dose Semaglutide - fda.gov

FDA Approves Fourth Product Under National Priority Voucher Program, Higher Dose Semaglutide  fda.gov Weight-loss treatment is on the verge of a dramatic shift – again  CNN FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share  CNBC FDA approves new higher-dose version of Wegovy shots  The Boston Globe Battle for weight-loss supremacy shifts from jabs to pills  Financial Times